Clinical Trial Update: Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydroxychloroquine for in-patients with symptomatic COVID-19; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease
• Respiratory Infection
• Sars-cov Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Coronavirus, Acute Respiratory Infection | Phase 3 | Status: COMPLETED | Results posted: 2021-03-17